Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in ... - MarketWatch (press release)
Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in .
FDA to Review CV Risk With Azithromycin - Medscape
FDA to Review CV Risk With AzithromycinMedscapeThat class, called macrolides, also includes clarithromycin (Biaxin, Abbott) and erythromycin, neither of which figured into the NEJM study.
Pernix launches new therapy to eradicate H. pylori - Pharmaceutical Business Review
Pernix launches new therapy to eradicate H.
Fighting Back Against Lyme Disease - Huffington Post
Fighting Back Against Lyme DiseaseHuffington PostFood enhances absorption of cefuroxime and of the extended-release form of clarithromycin.
Azithromycin Slightly Raises Risk of Cardiovascular Death - Family Practice News Digital Network
AFPAzithromycin Slightly Raises Risk of Cardiovascular DeathFamily Practice News Digital NetworkAzithromycin 'has been reported to be relatively free of cardiotoxic effects,' but it is closely related to erythromycin and clarithromycin, which are known to raise the risk of serious ventricular arrhythmias and sudden cardiac death.